MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...
MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...
Nick Guy is a staff senior editor for Buy Side. He's been reviewing personal technology, accessories and myriad other products for more than a decade. Edited By Written by Staff Editor, Buy Side ...
Titan Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was ...
MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...
A high-level overview of MS Emerging Markets Debt Fund (MSD). Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools.
The Tachometer is a flexible gauge that allows you to quickly convey detailed information in a way that can be intuitively understood. Many customizable features are included to configure the look and ...
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...
Learn more about the MS Emerging Markets Debt (MSD: XNYS) fund quote with Morningstar rating and analysis including NAV, star rating, asset allocation, capital gains, and dividends to help you stay up ...
Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results